PRMA Consulting || Improving Pharmaceutical Market Access in Asia-Pacific
Agilent SLIMS
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

27

Oct 2021

Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate

Teva Pharmaceutical Industries Ltd and MODAG GmbH today announced a strategic collaboration on the exclusive worldwide licensing and development of MODAGs lead compound anleb and a related compound sery Anleb targets pathological alphasynuclein oligomers and is being evaluated in patients with neuro...

27

Oct 2021

Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders

Boehringer Ingelheim and Thoeris GmbH announce a collaboration and license agreement with the aim to investigate novel firstinclass therapies for patients with urea cycle disorders UCDs UCDs are rare diseases caused by genetic liver dysfunctions leading to excess ammonia levels in the blood for whic...

26

Oct 2021

Xeris Pharmaceuticals Enters Collaboration Agreement With Merck

Xeris Biopharma Holdings Inc a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology neurology and gastroenterology today announced a collaboration agreement with Merck with an option to license Xeris suspensionbased formulation technolog...

26

Oct 2021

Tremeau Expands Pipeline with Novel Non-Opioid Compound for the Treatment of Acute Pain

Tremeau Pharmaceuticals today announced that the US Patent and Trademark Office USPTO has issued a Notice of Allowance for US Patent Application No Once issued the patent will provide composition of matter patent protection for Tremeaus novel deuteriumenriched etoricoxib compound TRM detoricoxib th...

25

Oct 2021

FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

Genentech a member of the Roche Group announced that the US Food and Drug Administration FDA has approved Susvimo ranibizumab injection mgmL for intravitreal use via ocular implant for the treatment of people with wet or neovascular agerelated macular degeneration AMD who have previously responded...

22

Oct 2021

Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates

Oncodesign a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine and TiumBio a company specializing in RD for rare diseases have announced the signature of a research collaboration agreement on RD of potential drug candidates for fibrosis Under this agree...

press releasesRead more...

26

Oct 2021

Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases

Vertex Pharmaceuticals Incorporated and Mammoth Biosciences a biotech company building the next generation of CRISPR products to cure and detect disease today announced a new partnership to develop in vivo geneediting therapies for two genetic diseases using Mammoths nextgeneration CRISPR systems

26

Oct 2021

Selecta Biosciences and Ginkgo Bioworks Announce Partnership to Advance Treatments for Orphan and Rare Diseases

Selecta Biosciences Inc a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses and Ginkgo Bioworks NYSE DNA the leading horizontal platform for cell programming today announced a collaboration

26

Oct 2021

Berkeley Lights Announces GSK Acquires Third Beacon® Optofluidic System to Expand Antibody Therapeutics Development

Berkeley Lights Inc a leader in digital cell biology today announced that GlaxoSmithKline NYSE GSK has purchased an additional Beacon Optofluidic system to expand its antibody therapeutics capacity The new Beacon system will leverage Berkeley Lights Opto Plasma B Discovery workflow to perform functi...

26

Oct 2021

Trillium Securityholders Approve Acquisition by Pfizer

Trillium Therapeutics Inc a clinical stage immunooncology company developing innovative therapies for the treatment of cancer today announced that its securityholders approved a statutory arrangement with PF Argentum ULC PF Argentum a whollyowned indirect subsidiary of Pfizer Inc at the special meet...

26

Oct 2021

Solasia and Nippon Kayaku Announce License Agreement in Japan for New Drug Candidate DARINAPARSIN (SP-02)

Solasia Pharma KK and Nippon Kayaku Co Ltd today jointly announced the conclusion of a license agreement for marketing rights to darinaparsin generic name development code SP in Japan hereinafter this agreement Darinaparsin is a drug candidate under development by Solasia for relapsed or refractory...

25

Oct 2021

Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research

Roche announced that it has launched the AVENIO Tumor Tissue CGP Kit The Kit complements the current CGP portfolio offered by Roche and Foundation Medicine and allows laboratories to expand their oncology research inhouse Ultimately a future version of the kit may lead to additional resources for cl...

EventsRead more...

25 - 27

Oct 2021

28 - 29

Oct 2021

29 - 01

Oct 2021

01 - 02

Nov 2021

03 - 07

Nov 2021

Napa Primary Care Conference 2021

Napa Valley Marriot Resort and Spa

10 - 14

Nov 2021

TOP ARTICLES

  • 3

    Metabolic Stability

    The liability of a drug substance to the metabolism is referred to as metabolic stability The liver uses CYPme...

KNOWLEDGE BANK

  • Interviews

    ExpreS<sup>2</sup>ion Biotechnologies

    Vice President - Business Development

    ExpreSion Biotechnologies protein expression system ExpreS is an important protein expression tool in the scientists tool box for protein expression The ExpreS platform has demonstrated in many instances its usefulness in RD with several ExpreSmade proteins having now been crystallized
  • Techno Trends

    Industry Watch: Turnaround from traditional ways of Pharmaceutical Testing

    Pharmaceutical testing has evolved itself from traditional way of animal testing and towards an economical and more efficient way of testing technology LiverChip Technology is the most sought after pharmaceutical testing available in the market Nowadays its buzzing everywhere due to various reasons like provision for creating an alternative model for D cell culture p...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...